Arachidonic Acid Market

Global Arachidonic Acid Market Size

The size of the global arachidonic acid market was expected to be worth USD 5.85 billion in 2025 and is anticipated to be worth USD 9.23 billion by 2034 from USD 6.15 billion In 2026, growing at a CAGR of 5.20% during the forecast period.

Arachidonic acid is a long-chain fatty acid that the human body uses to create unsaturated carboxylic acids. It is taken from a variety of food sources, including poultry, eggs, fish, and animal flesh, and is normally consumed in modest amounts. Mosses and algae can also be used to make it. It's found in a variety of foods, dietary supplements, infant formula, and medications, and comes in both dry and liquid versions. Arachidonic acid and docosahexaenoic acid (DHA) are combined to increase growth and development in children and to transmit signals to cell membranes to trigger adaptive changes in the event of muscle damage. It is given to adults and children in the form of tablets, injections, and syrups to meet their nutritional needs. One of the primary reasons driving the global arachidonic acid market expansion is a growing awareness of the importance of child nutrition among the general public.

Arachidonic acid is a fatty acid that is added to women's and baby meals to aid in the development of eyesight, immunological response, memory, and cell membranes. Furthermore, the rising incidence of lifestyle-related disorders, which is driving up demand for dietary supplements, is propelling the global arachidonic acid market forward. To meet daily nutritional requirements and lead a healthy lifestyle, consumers are increasingly turning to premium-quality oil-based nutritional supplements containing essential fatty acids. In accordance with this, the growing popularity of sports supplements among the general public is also contributing to the global arachidonic acid market's expansion. Other factors, including as substantial biotechnology research and development (R&D) activities, as well as rising consumer awareness of the benefits of keeping enough nutrition in their diet, are expected to propel the global arachidonic acid market forward.

MARKET DRIVERS 

Arachidonic acids are stored in cell membranes and provide signals indicating adaptive changes in the event of muscle damage.

The consumption of arachidonic acids in the form of tablets, injections, and/or syrups can compensate for a lack of naturally occurring arachidonic acids in the human body. Because of the quick technical breakthroughs and new patents recorded by the leading players in the market, the use of arachidonic acid in baby feeding is likely to expand over the forecast period.

This is related to newborns' demand for omega-6 fatty acids, which they cannot synthesis in sufficient amounts. As a result, the added supplement of ARA in infant food provides the needed fatty acids. The major components that aid in the development of cell membranes in infants' brains are DHA and arachidonic acid (ARA), a 20-carbon fatty acid. The amount of DHA and ARA in breast milk varies greatly between nations and is influenced by the mother's diet. In circumstances where the infant isn't getting enough ARA, it can be supplemented with ARA-fortified formula and later solid meals.

MARKET RESTRAINTS

Furthermore, rising regulatory acceptability of oil-based products in newborn nutrition is helping to fuel this expansion. Growing awareness of the product's benefits in baby nutrition has been cited as one of the main reasons for the rise in demand for infant formula. Also, the rising number of sporting events, increasing child care awareness, increasing demand for baby products, and rising awareness of the benefits offered by arachidonic acids are expected to present significant opportunities for the growth of the Arachidonic Acid Market in developing countries.However, the manufacture of arachidonic acids is subject to a number of intellectual property rights, which may stifle the expansion of the Arachidonic Acid Market at this time.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Form Insights

Solvents were the most popular form segment in the global arachidonic acid market, and they are expected to continue to rise in the future due to expanding product application scope. The ingredient is mostly found in infant formula and supplements, which are becoming increasingly popular around the world. Because of the increased profit margins involved, key corporations are concentrating on building innovative solvent-based product portfolios. Over the projected period, the solid form sector is expected to grow at the fastest rate.

Product demand in this area is being driven by an increase in the use of sports supplements. Growing customer desire for ARA-based supplements will have a positive impact in the coming years. Increased investment on sports nutrition will drive up product demand even further. Manufacturers are concentrating on developing nutritional products that meet international standards, which will help the industry grow.

By Application Insights

The global Arachidonic Acid (ARA) market is led by the infant formula segment, based on application. Polyunsaturated fatty acids have been shown to increase a baby's vision and memory, which is a major market driver. Furthermore, rising regulatory acceptability of oil-based products in newborn nutrition is helping to fuel this expansion. Growing awareness of the product's benefits in baby nutrition has been cited as one of the main reasons for the rise in demand for infant formula.

REGIONAL ANALYSIS

• With a volume share of nearly 40%, North America was the most important regional market. The presence of well-known corporations in North America was credited with this expansion. Because of developing sports and the newborn feeding business, particularly in the United States, and strong consumer purchasing capacity, the region is expected to grow even more throughout the forecast years.
• Europe is also a significant player in the worldwide industry. The key cause for this rise is the early usage of ARA in supplements and newborn formula. The area sector is also driven by factors such as excellent living standards and a well-developed sports nutrition market.
• Due to rising urbanization, an emerging middle-class population, and predicted expansion in the number of infants across the region, the Asia Pacific region is expected to have a significant CAGR. Global manufacturers are expanding their operations in APAC due to the presence of growing economies such as India and China, as well as the availability of low-cost raw materials and labor. This will also fuel the APAC region's industry.

KEY PLAYERS IN THE GLOBAL ARACHIDONIC ACID MARKET

Major Key Players in the Global Arachidonic Acid Market are A&Z Food additives Co. Ltd, Cayman Chemicals, Guangdong Runke, Cabio Bioengineering, Kingdomway, Suntory, Cargill, BASF, DSM and Others.

RECENT HAPPENINGS IN THE MARKET

• Dry n-3 powders were introduced by BASF, a renowned supplier of microencapsulated polyunsaturated fatty acid (PUFA) powders for newborn and maternal nutrition, food fortification, and nutritional supplements. These powders comprises of long shelf life and don't require refrigeration, as well as exceptional sensory qualities.
• The Food and Drug Administration has granted Cargill a GRAS non-objection letter for its arachidonic acid (ARA)-rich oil (ARA). The GRAS (Generally Recognized as Safe) accreditation will aid Cargillu2019s operations in the infant formula market with the omega-6 ingredient.

DETAILED SEGMENTATION OF THE GLOBAL ARACHIDONIC ACID MARKET INCLUDED IN THIS REPORT

This research report on the global arachidonic acid market has been segmented and sub-segmented based on form, application, and region.

By Form

• Solid
• Solvent

By Application

• Infant Formula
• Supplement

By Region

• North America
• Europe
• The Asia Pacific
• Latin America
• The Middle East and Africa